Skip to main content

Ischaemic stroke occurs when blood clots block blood supply to part of the brain, starving it of oxygen and leading to paralysis, brain damage, speech problems and other disabilities.

Someone all too familiar with the devastating impact of stroke is Beverley Bloomfield.

Beverley’s father suffered a heart attack when he was just 32, and at 36 had several strokes. But it didn’t end there. Beverley herself suffered a mini-stroke one Monday night as she was watching TV.

“I noticed a strange feeling on the right side of my head, then my arms and legs went limp. I sat there for two minutes, unable to move.”

For optimum recovery, it is vital that stroke sufferers get immediate treatment. Fortunately, Beverley managed to get to hospital in time.

But after decades of research and drug trials, there is still only one clinically approved drug to treat ischaemic stroke. This drug’s severe side effects – including increased bleeding in the brain – mean less than 10 per cent of patients presenting to hospital with symptoms of stroke are able to take it.

Over 90 per cent of people who have a stroke do not have an effective treatment to help them.

There is a critical need to develop more effective stroke therapies. Your support can help the thousands of stroke sufferers every year who currently cannot be treated.

Help protect people from stroke

We have developed a revolutionary new class of anti-clotting drug to treat stroke.

Stroke treatment requires prompt removal of the blood clot that triggered the stroke. Our drug, when combined with existing stroke treatments, dissolves the blood clot better than the existing drug alone, reduces the ability of the clot to re-occur, and importantly, does not increase bleeding.

We are working with collaborators to reach Phase II clinical trials: essentially testing the effectiveness of our drug in stroke patients.

With the successful completion of our next research phase, we could proceed to developing our drug commercially. Within five to ten years, we could have a better treatment for stroke on the market.

We cannot continue vital research like this without your help. Please support us today.

I consider myself lucky, unlike my Dad. He had no life at all after his strokes, and he passed away at 52.

Beverley, who suffered a mini-stroke

Please help us protect people from the ongoing disability stroke and other cardiovascular diseases can cause by making a tax-deductible donation today.

In thanks for your support, we’ve prepared a fact sheet about stroke that you can download below.